Active, Not Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
NCT03900429
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- East Valley Family Physicians Chandler, Arizona, United States
- The Institute for Liver Health - Chandler Chandler, Arizona, United States
- The Institute for Liver Health - Glendale Glendale, Arizona, United States